The standard pharmaceutical argument is that drug research has extreme fixed costs and very uncertain returns, so without patents no one would seek new drugs. This is both true and false, and evidence is limited because pharma is secretive. By the industry's own estimate, about 80% of the average cost of a new drug is clinical trials for FDA approval, not invention.

factualpending

Speaker

Michele Boldrin

Evidence Quote

“most of the cost this is this is nothing well known have nothing to do with the process of invention after do with the clinical trial”

Source

Michele Boldrin on Intellectual Property 05/18/2009— EconTalk
Created: 10/29/2026, 8:30:18 PM

Your notes

Loading notes...